ALTRIA GRP INC. DL-,333 (PHM7.HA)

Hanover - Hanover Prezzo differito. Valuta in EUR.

Aggiungi a watchlist

43,74

+0,26

(+0,59%)

Al 08:01AM CEST. Mercato aperto.

Capitalizzazione	N/D
Beta (5 anni mensile)	N/D
Rapporto PE (ttm)	N/D
EPS (ttm)	N/D
Prossima data utili	N/D
Rendimento e dividendo (forward)	N/D (N/D)
Data ex dividendo	N/D
Stima target 1A	N/D

Tutte

GlobeNewswire
Eyenovia Announces Appointments of Dr. Ellen Strahlman and Dr. Ram Palanki as New and Independent Members of its Board of Directors
NEW YORK, July 07, 2022 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (Nasdaq: EYEN), an ophthalmic pharmaceutical technology company developing a pipeline of late-stage microdose array print (MAP™) therapeutics, today announced that it has appointed Dr. Ellen Strahlman and Dr. Ram Palanki as new and independent members of its Board of Directors. With these appointments, the Eyenovia Board will expand to eight seats, from six currently. “I could not be more pleased to welcome Drs. Strahlman and Palanki to
FX Empire
Best Dividend Stocks to Buy Now for May 2022
Markets have continued to be volatile for a while as inflation rages. In the past, dividend paying stocks have proven to be good hedges for these kinds of environments.